ACR 2022 Tweet by Mike Putman

Exciting trial for PMR, SAPHYR RCT of sarilumab (IL6) in relapsing/refractory PMR

I interviewed Robert Speira aobut the trial for @RheumNow, arriving to your podcast inbox!

Overall very exciting, need options for this group and nice to see PMR getting attention

#ACR22 #ACRBest